Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
1.750
-0.140 (-7.41%)
At close: Dec 20, 2024, 4:00 PM
1.820
+0.070 (4.00%)
After-hours: Dec 20, 2024, 7:13 PM EST

Virax Biolabs Group Balance Sheet

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Cash & Equivalents
7.293.599.350.020.020.02
Short-Term Investments
0.10.080.050.01--
Cash & Short-Term Investments
7.383.679.40.030.020.02
Cash Growth
41.80%-61.00%33774.24%57.51%-22.06%-
Accounts Receivable
0---0-
Other Receivables
0.020.22----
Receivables
0.030.22--0-
Inventory
0.260.310.020.020.02-
Prepaid Expenses
0.360.190.21---
Total Current Assets
8.034.389.630.050.040.02
Property, Plant & Equipment
1.361.05----
Other Intangible Assets
0.050.050.18---
Total Assets
9.445.489.810.050.040.02
Accounts Payable
0.120.050.160.850.220.21
Accrued Expenses
0.30.080.550.40.460.25
Short-Term Debt
0.22-0.16-0.180.76
Current Portion of Leases
0.050.05----
Current Unearned Revenue
--0.04---
Other Current Liabilities
---00.020.02
Total Current Liabilities
0.690.170.911.250.871.24
Long-Term Leases
0.330.18----
Total Liabilities
1.030.350.911.250.871.24
Common Stock
000000
Retained Earnings
-21.28-18.53-11.79-6.34-4.63-3.98
Comprehensive Income & Other
29.9323.8920.925.363.982.92
Total Common Equity
8.645.379.13-0.97-0.65-1.06
Minority Interest
-0.23-0.23-0.22-0.22-0.18-0.16
Shareholders' Equity
8.425.148.9-1.2-0.83-1.22
Total Liabilities & Equity
9.445.489.810.050.040.02
Total Debt
0.60.220.16-0.180.76
Net Cash (Debt)
6.783.449.240.03-0.16-0.73
Net Cash Growth
34.93%-62.73%33181.39%---
Net Cash Per Share
2.541.728.690.03-0.66-7.02
Filing Date Shares Outstanding
4.342.571.79110.1
Total Common Shares Outstanding
4.342.571.5510.920.1
Working Capital
7.344.218.73-1.2-0.83-1.22
Book Value Per Share
1.992.095.87-0.98-0.70-10.12
Tangible Book Value
8.65.328.95-0.97-0.65-1.06
Tangible Book Value Per Share
1.982.075.76-0.98-0.70-10.12
Machinery
1.180.90.01---
Source: S&P Capital IQ. Standard template. Financial Sources.